Tofflon Science and Technology Group Future Growth
Future criteria checks 5/6
Tofflon Science and Technology Group is forecast to grow earnings and revenue by 49.1% and 27.5% per annum respectively while EPS is expected to grow by 48.6% per annum.
Key information
49.1%
Earnings growth rate
48.6%
EPS growth rate
| Medical Equipment earnings growth | 24.0% |
| Revenue growth rate | 27.5% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 15 Nov 2023 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2025 | 8,868 | 1,227 | 966 | 1,164 | 4 |
| 12/31/2024 | 7,459 | 1,023 | 774 | 1,223 | 4 |
| 3/31/2024 | 5,328 | 434 | -864 | -112 | N/A |
| 12/31/2023 | 5,642 | 600 | -1,019 | -324 | N/A |
| 9/30/2023 | 5,977 | 826 | -920 | -200 | N/A |
| 6/30/2023 | 5,993 | 870 | -774 | -3 | N/A |
| 3/31/2023 | 5,655 | 866 | -314 | 405 | N/A |
| 1/1/2023 | 5,469 | 847 | -479 | 247 | N/A |
| 9/30/2022 | 5,127 | 874 | -216 | 510 | N/A |
| 6/30/2022 | 4,810 | 890 | 112 | 711 | N/A |
| 3/31/2022 | 4,713 | 929 | 426 | 965 | N/A |
| 1/1/2022 | 4,192 | 828 | 915 | 1,369 | N/A |
| 9/30/2021 | 3,726 | 733 | 1,334 | 1,572 | N/A |
| 6/30/2021 | 3,328 | 632 | 1,283 | 1,424 | N/A |
| 3/31/2021 | 2,921 | 527 | 1,225 | 1,259 | N/A |
| 12/31/2020 | 2,708 | 463 | 1,089 | 1,116 | N/A |
| 9/30/2020 | 2,658 | 373 | 741 | 751 | N/A |
| 6/30/2020 | 2,527 | 280 | 625 | 641 | N/A |
| 3/31/2020 | 2,329 | 177 | 511 | 524 | N/A |
| 12/31/2019 | 2,264 | 146 | 432 | 446 | N/A |
| 9/30/2019 | 2,031 | 65 | 308 | 348 | N/A |
| 6/30/2019 | 1,926 | 66 | 291 | 323 | N/A |
| 3/31/2019 | 1,894 | 65 | 284 | 317 | N/A |
| 12/31/2018 | 1,917 | 70 | 190 | 222 | N/A |
| 9/30/2018 | 1,886 | 78 | 144 | 172 | N/A |
| 6/30/2018 | 1,856 | 84 | 65 | 101 | N/A |
| 3/31/2018 | 1,735 | 93 | 10 | 47 | N/A |
| 12/31/2017 | 1,725 | 123 | N/A | 21 | N/A |
| 9/30/2017 | 1,535 | 160 | N/A | 25 | N/A |
| 6/30/2017 | 1,387 | 174 | N/A | 7 | N/A |
| 3/31/2017 | 1,355 | 200 | N/A | 21 | N/A |
| 12/31/2016 | 1,328 | 235 | N/A | 107 | N/A |
| 9/30/2016 | 1,433 | 297 | N/A | 130 | N/A |
| 6/30/2016 | 1,491 | 331 | N/A | 102 | N/A |
| 3/31/2016 | 1,591 | 372 | N/A | 89 | N/A |
| 12/31/2015 | 1,556 | 387 | N/A | 141 | N/A |
| 9/30/2015 | 1,449 | 391 | N/A | 79 | N/A |
| 6/30/2015 | 1,415 | 376 | N/A | 136 | N/A |
| 3/31/2015 | 1,349 | 369 | N/A | 86 | N/A |
| 12/31/2014 | 1,259 | 335 | N/A | 55 | N/A |
| 9/30/2014 | 1,153 | 278 | N/A | 98 | N/A |
| 6/30/2014 | 1,106 | 281 | N/A | 118 | N/A |
| 3/31/2014 | 1,065 | 271 | N/A | 361 | N/A |
| 12/31/2013 | 1,021 | 266 | N/A | 339 | N/A |
| 9/30/2013 | 1,064 | 270 | N/A | 352 | N/A |
| 6/30/2013 | 1,006 | 258 | N/A | 403 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 300171's forecast earnings growth (49.1% per year) is above the savings rate (2.9%).
Earnings vs Market: 300171's earnings (49.1% per year) are forecast to grow faster than the CN market (24.4% per year).
High Growth Earnings: 300171's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 300171's revenue (27.5% per year) is forecast to grow faster than the CN market (14.7% per year).
High Growth Revenue: 300171's revenue (27.5% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 300171's Return on Equity is forecast to be high in 3 years time